Literature DB >> 12769761

Hepatitis C virus clearance: the enigma of failure despite an impeccable survival strategy.

Maria G Isaguliants1.   

Abstract

Infection with human hepatitis C virus (HCV) as a result of a bilateral process of host-virus interactions. There are factors on both sides that contribute to clearance and to chronicity. Virus strategy to survive is built on several basic features. The first, recently recognized, is a wide cell tropism. HCV can infect not only hepatocytes, but also cells of immune system (B-cells, monocytes, macrophages, dendritic cells), epithelium, and immunologically privileged sites such as the central nervous system. Dendritic cells and platelets can also be passive virus carriers. Possibilities of virus clearance or abortive inapparent HCV infection at the stage of adsorption are considered. The second feature is rapid error-prone replication that leads to accumulation within one host of multiple virus variants (quasispecies). Viral heterogeneity could be multiplied by recombination of HCV genomic/subgenomic RNA molecules. Quasispecies nature gives virus an advantage in adaptation to varying host environment including availability of permissive cells, the presence of innate and adaptive immune response, and antiviral treatment. Analysis of HCV polymorphisms and their evolution rates may pinpoint the molecular (sequence) correlates of HCV clearance. The third feature is the capacity to modify or adapt host milieu. HCV core, envelope E2 and nonstructural NS2, NS3, NS5A proteins seem to hold a grip over the host cellular functions by down-regulating processes unfavorable and up-regulating processes favorable for virus replication and persistence. The relevance of the latter interactions to HCV infection outcome remains to be demonstrated. This review discusses recent developments in this area of HCV research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12769761     DOI: 10.2174/1389201033489856

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  5 in total

1.  Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.

Authors:  A J Demetris; B Eghtesad; A Marcos; K Ruppert; M A Nalesnik; P Randhawa; T Wu; A Krasinskas; P Fontes; T Cacciarelli; A O Shakil; N Murase; J J Fung; T E Starzl
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

2.  Efficient error correction for next-generation sequencing of viral amplicons.

Authors:  Pavel Skums; Zoya Dimitrova; David S Campo; Gilberto Vaughan; Livia Rossi; Joseph C Forbi; Jonny Yokosawa; Alex Zelikovsky; Yury Khudyakov
Journal:  BMC Bioinformatics       Date:  2012-06-25       Impact factor: 3.169

3.  Hepatitis C virus antigenic convergence.

Authors:  David S Campo; Zoya Dimitrova; Jonny Yokosawa; Duc Hoang; Nestor O Perez; Sumathi Ramachandran; Yury Khudyakov
Journal:  Sci Rep       Date:  2012-02-15       Impact factor: 4.379

4.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08

5.  Next-generation sequencing reveals large connected networks of intra-host HCV variants.

Authors:  David S Campo; Zoya Dimitrova; Lilian Yamasaki; Pavel Skums; Daryl Ty Lau; Gilberto Vaughan; Joseph C Forbi; Chong-Gee Teo; Yury Khudyakov
Journal:  BMC Genomics       Date:  2014-07-14       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.